ArticleJournal of medical signals and sensors2026
Diagnosing Multiple Sclerosis from Magnetic Resonance Imaging Images: Highlights from the Second Isfahan Artificial Intelligence Event 2024.
Article in Journal of medical signals and sensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system which is the main reason of disabilities of young adults. MS occurs when the immune system attacks the central nervous system and destroys the myelin sheaths of neurons. Loss of myelin sheaths results in appearing several lesions in different parts of the brain. The place and amount of lesions are important criteria for determining the level and progression of the disease. These parameters are usually determined manually by an expert which can be time-consuming and inaccurate. Methods: Considering the effectiveness of artificial intelligence (AI)-based methods in diagnosing and predicting different diseases, and the increasing need for driving new and effective diagnostic methods, this challenge, entitled "Diagnosing MS from magnetic resonance imaging (MRI) Images," has been organized by Isfahan Province Elites Foundation in collaboration with Medical Image and Signal Processing Research Center of Isfahan University of Medical Sciences, as a part of Isfahan AI 2024 event, held in October 2024 in Isfahan, Iran. The challenge has been dedicated to find new AI-based methods for the segmentation and localization of lesions in MRI images of patients with MS. The challenge had three steps, where in the first and second steps, the teams received the train and test datasets, respectively. Finally, the selected teams were invited to the last round of the competition, held in person, and received the last test dataset. Results: Based on the received results, the best achieved dice score was 0.33, best sensitivity was 0.349, best precision was 0.3, and the lowest centroid distance was 53.025. In addition, the best accuracy for lesion detection in periventricular, deep white matter, juxtacortical, and infratentorial parts of the brain was 80.282%, 74%, 63.492%, and 62.5%, respectively. Conclusion: Several methods, mostly based on deep learning, have been submitted. The results show that AI has the ability for the segmentation and localization of lesions. However, the received results are still far from the desired accuracy, which shows a need for further improvement and studies in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.